The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity
Abstract
An increasing body of evidence has linked AMP-activated protein kinase (AMPK) and malonyl coenzyme A (CoA) to the regulation of energy balance. Thus, factors that activate AMPK and decrease the concentration of malonyl CoA in peripheral tissues, such as exercise, decrease triglyceride accumulation in the adipocyte and other cells. The data reviewed here suggest that this is related to the fact that these factors concurrently increase fatty acid oxidation, decrease the esterification of fatty acids to form glycerolipids, and, by mechanisms still unknown, increase energy expenditure. Malonyl CoA contributes to these events because it is an allosteric inhibitor of carnitine palmitoyltransferase, the enzyme that controls the transfer of long-chain fatty acyl CoA from the cytosol to the mitochondria, where they are oxidized. AMPK activation in turn increases fatty acid oxidation (by effects on enzymes that govern malonyl CoA synthesis and possibly its degradation) and inhibits triglyceride synthesis. It also increases the expression of uncoupling proteins and the transcriptional regulator peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC1alpha), which could possibly increase energy expenditure. Recent studies suggest that the ability of leptin, adiponectin, 5'-aminoimidazole 4-carboxamide riboside (AICAR), adrenergic agonists, and metformin to diminish adiposity may be mediated, at least in part, by AMPK activation in peripheral tissues. In addition, preliminary studies suggest that malonyl CoA and AMPK take part in fuel-sensing and signaling mechanisms in the hypothalamus that could regulate food intake and energy expenditure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While these data suggest a potential use of these compounds in improving skeletal muscle function and increasing energy expenditure, the safety issue of using AICAR or other drugs targeting AMPK needs to be considered 162.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [162]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
Neel, J. V. (1962) · Europe PMC (PubMed Central) · Cited by 3,172
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
(1962) · PubMed Central · Cited by 2,182
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 2×
“Malonyl CoA is both an intermediate in the de novo synthesis of long-chain fatty acids and an inhibitor of carnitine palmitoyltransferase (CPT1), the enzyme that controls the transfer of long-chain fatty acyl CoA into mitochondria (7) (Fig.”
Flagged first, then by citations
Cited by
Sorted by citations
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,042
Cool, B. L., Zinker, B. A., Chiou, W. J. H., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A. L., Gagné, G. D., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 939
Yajnik, C. S., Deshpande, S. S., Jackson, A. A., Refsum, H., Rao, S., Fisher, D. J., Bhat, D., Naik, S. S., Coyaji, K., Joglekar, C. V., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0793-y · Cited by 789
AMP-activated Protein Kinase Plays a Role in the Control of Food Intake
Andersson-Hall, U. K., Filipsson, K., Abbott, C. R., Woods, A., Smith, K. L., Bloom, S. R., Carling, D., & Small, C. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300557200 · Cited by 777
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates
Jobgen, W. S., Fried, S. K., Fu, W. J., Meininger, C. J., & Wu, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.12.001 · Cited by 729
Meeting the energetic demands of insect diapause: Nutrient storage and utilization
Hahn, D. A., & Denlinger, D. L. (2007) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2007.03.018 · Cited by 678
Cellular bioenergetics as a target for obesity therapy
Tseng, Y.-H., Cypess, A. M., & Kahn, C. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3138 · Cited by 591
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Sanders, F., & Griffin, J. L. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12178 · Cited by 585
AMPK: restoring metabolic homeostasis over space and time
Trefts, E., & Shaw, R. J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.015 · Cited by 478
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Self-citationPhysical activity and modulation of systemic low-level inflammation
Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429
Flachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P., Franssen-van Hal, N., Ruzickova, J., Sponarova, J., Drahota, Z., Vlcek, C., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1944-7 · Cited by 388
Ellis, J. M., Li, L. O., Wu, P.-C., Koves, T. R., Ilkayeva, O., Stevens, R. D., Watkins, S. M., Muoio, D. M., & Coleman, R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.012 · Cited by 367
Adiponectin, the missing link in insulin resistance and obesity
GILCAMPOS, M. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.04.010 · Cited by 353
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 361
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345
Brusq, J.-M. G., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., & Issandou, M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600020-jlr200 · Cited by 344
Leptin: Structure, Function and Biology
Zhang, F. P. Y., Chen, Y., Heiman, M. L., & DiMarchi, R. D. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71012-8 · Cited by 353
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism
Qi, L., Heredia, J. E., Altarejos, J. Y., Screaton, R., Goebel, N., Niessen, S., MacLeod, I. X., Liew, C. W., Kulkarni, R. N., Bain, J., et al. (2006) · Science · doi:10.1126/science.1123374 · Cited by 288
Kim, E. K., Miller, I., Aja, S. M., Landree, L. E., Pinn, M. L., McFadden, J. M., Kuhajda, F. P., Moran, T. H., & Ronnett, G. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402165200 · Cited by 313
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise.
Kelly, M., Keller, C., Avilucea, P. R., Keller, P., Luo, Z., Xiang, X., Giralt, M., Hidalgo, J., Saha, A. K., Pedersen, B. K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.188 · Cited by 289
Self-citationReceptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., & Russo, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.033 · Cited by 275
Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation
Boren, J., & Brindle, K. M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.34 · Cited by 259
The Role of the Carnitine System in Human Metabolism
Foster, D. W. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.001 · Cited by 231
Minireview: Nutrient Sensing and the Regulation of Insulin Action and Energy Balance
Obici, S., & Rossetti, L. (2003) · Endocrinology · doi:10.1210/en.2003-0999 · Cited by 222
Ghrelin: a hormone regulating food intake and energy homeostasis
Gil‐Campos, M., Aguilera, C. M., Cañete, R., & Gil, Á. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061787 · Cited by 218
Park, J., Rho, H. K., Kim, K. H., Choe, S. S., Lee, Y. S., & Kim, J. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5146-5157.2005 · Cited by 212
Adipocyte CREB Promotes Insulin Resistance in Obesity
Qi, L., Saberi, M., Zmuda, E. J., Wang, Y., Altarejos, J. Y., Zhang, X., Dentin, R., Hedrick, S., Bandyopadhyay, G. K., Hai, T., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.006 · Cited by 196
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Joshi, T., Singh, A. K., Haratipour, P., Sah, A. N., Pandey, A. K., Naseri, R., Juyal, V., & Farzaei, M. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28528 · Cited by 180
Structure and regulation of acetyl-CoA carboxylase genes of metazoa
BARBER, M. C., Price, N. T., & Travers, M. T. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.12.001 · Cited by 177
Shinmura, K., Tamaki, K., Saito, K., Nakano, Y., Tobe, T., & Bolli, R. (2007) · Circulation · doi:10.1161/circulationaha.107.725697 · Cited by 171
AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes
Dagon, Y., Avraham, Y., & Berry, E. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.159 · Cited by 171
Ramamurthy, S., & Ronnett, G. V. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.110122 · Cited by 161
Gomes, A. P., Duarte, F. V., Nunes, P., Hubbard, B. P., Teodoro, J. S., Varela, A. T., Jones, J. G., Sinclair, D. A., Palmeira, C. M., & Rolo, A. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.008 · Cited by 159
Villena, J. A., Viollet, B., Andreelli, F., Kahn, A., Vaulont, S., & Sul, H. S. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2242 · Cited by 164
Batchuluun, B., Inoguchi, T., Sonoda, N., Sasaki, S., Inoue, T., Fujimura, Y., Miura, D., & Takayanagi, R. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.025 · Cited by 161
Gable, D. R., Hurel, S. J., & Humphries, S. E. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.010 · Cited by 160
Nur77 Regulates Lipolysis in Skeletal Muscle Cells
Maxwell, M., Cleasby, M. E., Harding, A. S., Stark, A., Cooney, G. J., & Muscat, G. E. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409580200 · Cited by 159
Zhou, W., Han, W. F., Landree, L. E., Thupari, J. N., Pinn, M. L., Bililign, T., Kim, E. K., Vadlamudi, A., Medghalchi, S. M., Meskini, R. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3439 · Cited by 157
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 160
López, M., Lelliott, C. J., Tovar, S. A., Kimber, W. L., Gallego, R., Virtue, S., Blount, M., Vazquez, M. J., Finer, N., Powles, T. J., et al. (2006) · Diabetes · doi:10.2337/db05-1356 · Cited by 151
Self-citationRegulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
Gathercole, L. L., Morgan, S. A., Bujalska, I. J., Hauton, D., Stewart, P. M., & Tomlinson, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026223 · Cited by 150
Yu, X., McCorkle, S. K., Wang, M., Lee, Y., Li, J., Saha, A. K., Unger, R. H., & Ruderman, N. B. (2004) · Diabetologia · doi:10.1007/s00125-004-1570-9 · Cited by 151
Self-citationFatty acid oxidation and meiotic resumption in mouse oocytes
Downs, S. M., Mosey, J. L., & Klinger, J. E. (2009) · Molecular Reproduction and Development · doi:10.1002/mrd.21047 · Cited by 148
KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity
Costanzo-Garvey, D. L., Pfluger, P. T., Dougherty, M. K., Stock, J. L., Boehm, M. B., Chaika, O. V., Fernandez, M. R., Fisher, K. W., Kortum, R. L., Hong, E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.010 · Cited by 148
Glucocorticoid-Induced Fatty Liver Disease
Rahimi, L., Rajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s247379 · Cited by 151
Hypothalamic fatty acid metabolism: A housekeeping pathway that regulates food intake
López, M., Lelliott, C. J., & Vidal‐Puig, A. (2007) · BioEssays · doi:10.1002/bies.20539 · Cited by 150
Nawrocki, A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 144
Ye, J.-M., Dzamko, N. L., Cleasby, M. E., Hegarty, B. D., Furler, S. M., Cooney, G. J., & Kraegen, E. W. (2004) · Diabetologia · doi:10.1007/s00125-004-1436-1 · Cited by 138
Self-citationFuel economy in food‐deprived skeletal muscle: signaling pathways and regulatory mechanisms
de Lange, P., Moreno, M., Silvestri, E., Lombardi, A., Goglia, F., & Lanni, A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8527rev · Cited by 137
The Role of Impaired Mitochondrial Lipid Oxidation in Obesity
Rogge, M. M. (2009) · Biological Research For Nursing · doi:10.1177/1099800408329408 · Cited by 142
Bézaire, V., Spriet, L. L., Campbell, S., Sabet, N., Gerrits, M. F., Bonen, A., & Harper, M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2765fje · Cited by 133
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127
Kim, E. J., Jung, S., Son, K. H., Kim, S. R., Ha, T. Y., Park, M. G., Jo, I. G., Park, J. G., Choe, W., Kim, S. S., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034447 · Cited by 122
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
Wahl, D. R., Byersdorfer, C. A., Ferrara, J. L. M., Opipari, A. W., & Glick, G. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01148.x · Cited by 125
Park, J.-A., Pichiah, P. B. T., Yu, J., Oh, S., Daily, J. W., & Cha, Y. (2012) · Journal of Applied Microbiology · doi:10.1111/jam.12017 · Cited by 120
The role of the adipocyte hormone adiponectin in cardiovascular disease
Hug, C., & Lodish, H. F. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.001 · Cited by 113
Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome
Aguilera, C. M., Gil‐Campos, M., Cañete, R., & Gil, Á. (2008) · Clinical Science · doi:10.1042/cs20070115 · Cited by 112
Gaidhu, M. P., Fediuc, S., & Ceddia, R. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602992200 · Cited by 111
Shinmura, K., Tamaki, K., & Bolli, R. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.03.010 · Cited by 104
Bowman, C. E., Rodriguez, S., Alpergin, E. S. S., Acoba, M. G., Zhao, L., Härtung, T., Claypool, S. M., Watkins, P. A., & Wolfgang, M. J. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.04.009 · Cited by 103
Kusunoki, J., Kanatani, A., & Moller, D. E. (2006) · Endocrine · doi:10.1385/endo:29:1:91 · Cited by 104
Taylor, E. B., Lamb, J. D., Hurst, R. W., Chesser, D. G., Ellingson, W. J., Greenwood, L. J., Porter, B. B., Herway, S. T., & Winder, W. W. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2005 · Cited by 102
Beyond Obesity: The Diagnosis and Pathophysiology of Metabolic Syndrome
Gade, W., Schmit, J. M., Collins, M., & Gade, J. (2010) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.23.1.51 · Cited by 100
Kang, S. W. S., Haydar, G., Taniane, C., Farrell, G. C., Arias, I. M., Lippincott‐Schwartz, J., & Fu, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165638 · Cited by 102
Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone
Wang, M.-Y., & Unger, R. H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2004 · Cited by 107
Wu, C., Kang, J., Peng, L.-J., Li, H., Khan, S. A., Hillard, C. J., Okar, D. A., & Lange, A. J. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.003 · Cited by 100
Guo, H., Liu, G., Zhong, R., Wang, Y., Wang, D., & Xia, M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-10 · Cited by 101
Fatty acid oxidation and photoreceptor metabolic needs
Fu, Z., Kern, T. S., Hellström, A., & Smith, L. E. H. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000618 · Cited by 98
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Gomez‐Galeno, J., Dang, Q., Nguyen, T. H., Boyer, S. H., Grote, M. P., Sun, Z., Chen, M., Craigo, W. A., van Poelje, P. D., MacKenna, D. A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100143q · Cited by 99
El-Assaad, W., Joly, E. C., Barbeau, A., SLADEK, R. M., Buteau, J., Maestre, I., Pépin, É., Zhao, S., Iglesias, J., Roche, E., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1238 · Cited by 96
Aires, C. C. P., IJlst, L., Stet, F. S., Prip‐Buus, C., de Almeida, I. T., Durán, M., Wanders, R. J. A., & Silva, M. F. B. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.011 · Cited by 95
Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance
de Morentin, P. B. M., González, C. R., Saha, A. K., Martins, L., Diéguez, C., Vidal‐Puig, A., Tena‐Sempere, M., & López, M. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9165-5 · Cited by 96
Self-citationGhrelin and lipid metabolism: key partners in energy balance
Varela, L., Vazquez, M. J., Cordido, F., Nogueiras, R., Vidal‐Puig, A., Diéguez, C., & López, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0068 · Cited by 95
Structural Properties of AMP-activated Protein Kinase
Riek, U., Scholz, R., Konarev, P. V., Rufer, A. C., Suter, M., Nazabal, A., Ringler, P., Chami, M., Müller, S. A., Neumann, D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708379200 · Cited by 93
Reduced oxidation of dietary fat after a short term high-carbohydrate diet
Roberts, R., Bickerton, A. S. T., Fielding, B. A., Blaak, E. E., Wagenmakers, A. J. M., Chong, M. F., Gilbert, M., Karpe, F., & Frayn, K. N. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.824 · Cited by 92
Zang, Y., Fan, L., Chen, J., Huang, R., & Qin, H. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01831 · Cited by 92
Minireview: The Brain as a Molecular Target for Diabetic Therapy
Prodi, E., & Obici, S. (2006) · Endocrinology · doi:10.1210/en.2006-0143 · Cited by 88
Villarroya, F., Domingo, P., & Giralt, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.005 · Cited by 86
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
Menéndez, J., & Lupu, R. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.4 · Cited by 76
κ‐Opioid receptors control the metabolic response to a high‐energy diet in mice
Czyzyk, T. A., Nogueiras, R., Lockwood, J. F., McKinzie, J. H., Coşkun, T., Pintar, J. E., Hammond, C., Tschöp, M. H., & Statnick, M. A. (2009) · The FASEB Journal · doi:10.1096/fj.09-143610 · Cited by 82
Dziedzic, B., Szemraj, J., Bartkowiak, J., & Walczewska, A. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01541.x · Cited by 81
Paglialunga, S., Schrauwen, P., Roy, C., Moonen‐Kornips, E., Lü, H., Hesselink, M. K. C., Deshaies, Y., Richard, D., & Cianflone, K. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0205 · Cited by 77
Murça, T. M., Moraes, P. L., Capuruço, C. A., Santos, S. H. S., Melo, M. B., Santos, R. A. S., Shenoy, V., Katovich, M. J., Raizada, M. K., & Ferreira, A. J. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.05.093 · Cited by 75
Cammisotto, P., Londoño, I., Gingras, D., & Bendayan, M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00373.2007 · Cited by 72
Osler, M. E., & Zierath, J. R. (2007) · Endocrinology · doi:10.1210/en.2007-1441 · Cited by 73
The effect of clozapine on the AMPK-ACC-CPT1 pathway in the rat frontal cortex
Kim, M. K., Kim, S. H., Yu, H. S., Park, H. G., Kang, U. G., Ahn, Y. M., & Kim, Y. S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000976 · Cited by 72
Kim, M., & Lee, K. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0659-z · Cited by 71
Hypothalamic lipotoxicity and the metabolic syndrome
de Morentin, P. B. M., Varela, L., Fernø, J., Nogueiras, R., Diéguez, C., & López, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.016 · Cited by 73
Zhou, X., Chen, J., Chen, J., Wu, W.-C., Wang, X., & Wang, Y. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.014 · Cited by 69
Hashimoto, T., Segawa, H., Okuno, M., Kano, H., Hamaguchi, H., Haraguchi, T., Hiraoka, Y., Hasui, S., Yamaguchi, T., Hirose, F., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.113084 · Cited by 69
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181995 · Cited by 69
Kinote, A. P. B. D. M., Faria, J. A., Roman, E. A., Solon, C., Razolli, D. S., Ignácio-Souza, L. M., Sollon, C. S., do Nascimento, L. F. R., de Araújo, T. M., Barbosa, A. P. L., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1341 · Cited by 73
Diet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & Sugden, M. C. (2006) · Clinical Science · doi:10.1042/cs20060150 · Cited by 62
Taïb, B., Bouyakdan, K., Hryhorczuk, C., Rodaros, D., Fulton, S., & Alquier, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506238 · Cited by 65
PPARs and the orchestration of metabolic fuel selection
Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64
AMPK activators – potential therapeutics for metabolic and other diseases
Zhou, G., Sebhat, I. K., & Zhang, B. B. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01967.x · Cited by 63
Metadata
- Authors
- Ruderman, N. B., Saha, A. K., & Kraegen, E. W.
- Affiliations
- Boston University (US)
- Garvan Institute of Medical Research (AU)
- Corresponding author
- Ruderman, Neil B.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-12
- Volume
- 144
- Issue
- 12
- Pages
- 5166-5171
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2055061083
- Cited by
- 266
- References
- 54
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 10 · 2020: 5 · 2019: 10 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 8 · 2012: 26
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk019514-35)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-19514)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- malonyl-CoA, AMPK, adiposity, energy balance, fatty acid oxidation, carnitine palmitoyltransferase, triglyceride synthesis, uncoupling proteins, PGC-1α, leptin, adiponectin, AICAR, metformin, sympathomimetic drugs, food intake regulation, energy expenditure
- MeSH terms
- Adipose Tissue, Animals, Humans, Malonyl Coenzyme A, Multienzyme Complexes, Obesity, Protein Serine-Threonine Kinases, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review